> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# MXBBB Recalls Umary Hyaluronic Acid Tablets
- URL: https://www.fdaweb.com/mxbbb-recalls-umary-hyaluronic-acid-tablets/
- Published: 2024-11-21T12:00:00.000Z
- Updated: 2026-09-14T14:47:46.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5158238

FDA says MXBBB has recalled one lot of Umary Acid Hyaluronic, 30 caplets 850 mg, to the consumer level. An agency [notice](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/mxbbb-issues-voluntary-nationwide-recall-umary-acid-hyaluronic-due-presence-diclofenac-and?ref=fdaweb.com) says the product contains undeclared diclofenac and omeprazole, as confirmed by FDA laboratory analysis.

Umary was distributed nationwide by Amazon, the notice says. It says MXBBB had not received any reports of adverse events as of the 11/19 recall date.